Document is current
Any future updates will be listed below
-
Authors
Ilbegi, Shahrzad https://orcid.org/0000-0001-8165-9314
Groenman, Annabeth P.
Schellekens, Arnt
Hartman, Catharina A.
Hoekstra, Pieter J.
Franke, Barbara
Faraone, Stephen V.
Rommelse, Nanda N. J.
Buitelaar, Jan K.
-
Funding
Funding for this research was provided by:
National Institute of Health (R01MH62873)
Nederlandse organisatie voor Wetenschappelijk Onderzoek Large Investment Grant (1750102007010)
ZonMW (60-60600-97-193)
Nederlandse organisatie voor Wetenschappelijk Onderzoek (056-13-015)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (433-09-242)
European Community’s Seventh Framework Programme (278948)
Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam (matching grants)
European Community’s Seventh Framework Programme (unrestricted education grant by Shire)
- License Information
-
More Information
Article History
Received: 18 July 2018
Accepted: 9 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: All participants gave informed consent and the study was approved by ethical committees of University Medical Center Utrecht and Arnhem-Nijmegen. Reference numbers: 97/268, 2008/163 and 2012/542.
: Not applicable.
: JKB has been in the past 3 years a consultant to / member of advisory board of / and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Medice, Novartis, and Servier. He has received research support from Roche and Vifor. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. BF has received educational speaking fees from Shire and Medice. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
